Atlas Trials

Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease

Clinical trial NCT02656017 · COMPLETED

Trial details

NCT number
NCT02656017
Sponsor
Kyongtae Ty Bae, M.D., Ph.D.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Polycystic Kidney, Autosomal Dominant
Start date
2016-06-27
Primary completion
2020-12-07
Enrollment
97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.